LETTER
Synthesis of Diarylbenzazepines
2869
aryl ketone to 2-fluoroaniline is used in the reaction. The
extra amine may be needed to scavenge the proton that is
lost during the cyclization (see later). We attempted to
employ the 2:1 stoichiometry with inclusion of either
pyridine, N,N-(dimethylamino)pyridine, or 2,6-dimethyl-
aniline to scavenge the proton, but conversion to benz-
azepine in these cases was very low.
Acknowledgment
K.R. acknowledges financial support from the Professional Staff
Congress of the City University of New York. We are grateful to Dr.
Cliff Soll of the CUNY Mass Spectrometry Facility at Hunter
College for recording the high-resolution mass spectra.
References and Notes
Scheme 2 shows a possible mechanism. After acid-cata-
lyzed imine formation, further heating may cause an al-
dol-like condensation, giving 3. In support of this, we
have found that reaction between 2-fluoroaniline and 1,3-
diphenyl-2-butenone (the aldol product of acetophenone)
will give benzazepine 2 under these conditions. Com-
pound 3 may then isomerize to 4 via a series of three acid-
catalyzed proton migrations. Compound 4 could then lose
fluoride ion and cyclize to give cation 5. The key to suc-
cess of the reaction may be at this stage. The pair of aryl
groups provided by the ketones may be needed to stabilize
the cation 5, explaining why the reaction did not give
benzazepine when 4-methyl-2-pentanone was used (see
above). In order for the aryl groups to exert the maximum
effect, they should be co-planar with the rest of the conju-
gated system of cation 5. This could explain the failure of
both 2¢-methylacetophenone and propiophenone to give
useful yields of benzazepine (see above); in these cases,
the aryl groups of cation 5 cannot be co-planar with the
rest of the system.
(1) Kudzma, L. Synthesis 2003, 1661.
(2) Brooke, G. M.; Matthews, R. S. J. Fluorine Chem. 1988, 40,
109.
(3) Sudo, K.; Miyazaki, Y.; Kojima, N.; Kobayashi, M.; Suzuki,
H.; Shintani, M.; Shimizu, Y. Antiviral Res. 2005, 65, 125.
(4) Seto, M.; Miyamoto, N.; Aikawa, K.; Aramaki, Y.; Kanzaki,
N.; Iizawa, Y.; Baba, M.; Shiranishi, M. Bioorg. Med. Chem.
2005, 13, 363.
(5) Qadir, M.; Priestley, R. E.; Rising, T. W. D. F.; Gelbrich, T.;
Coles, S. J.; Hursthouse, M. B.; Sheldrake, P. W.; Whittall,
N.; Hii, K. K. Tetrahedron Lett. 2003, 44, 3675.
(6) Typical Procedure
A solution of 6.7 mmol of the 2-fluoroaniline, 6.7 mmol of
the aryl methyl ketone, and 40 mg of PTSA in 30 mL of
toluene or xylenes in a Dean–Stark apparatus was heated at
reflux until the initially formed imine was converted into
benzazepine, as judged by silica gel TLC. After cooling, the
solution was washed with 5% NaHCO3 solution and dried
over MgSO4. Removal of the solvent under reduced pressure
gave dark oil or solid, which was triturated with EtOAc–
hexanes to isolate a first crop of benzazepine. Additional
product can be obtained by taking a second crop, or
purification by silica gel chromatography, eluting with
EtOAc–hexanes. Analytically pure samples can be obtained
by recrystallization from EtOAc–hexanes.
2,4-Bis(4-methoxyphenyl)-3H-1-benzazepine (2a)
Mp 159–160 °C. 1H NMR (300 MHz, CDCl3): d = 7.86 (d, 2
H, J = 9 Hz), 7.56–7.15 (m, 4 H), 7.49 (d, 2 H, J = 9 Hz),
6.98 (s, 1 H), 6.91 (d, 2 H, J = 9 Hz), 6.85 (d, 2 H, J = 9 Hz),
3.82 (s, 3 H), 3.78 (s, 3 H), 3.32 (br s, 2 H). 13C NMR (75
MHz, CDCl3): d = 161.30, 159.43, 156.30, 146.88, 134.37,
132.63, 130.88, 130.45, 129.70, 128.08, 127.90, 126.61,
125.29, 123.53, 114.12, 113.84, 55.32, 55.31, 33.67. Anal.
Calcd for C24H21NO2 (355.43): C, 81.10; H, 5.96; N, 3.94.
Found: C, 80.95; H, 6.17; N, 3.78.
2,4-Bis(3-methoxyphenyl)-3H-1-benzazepine (2b)
Mp 109–110 °C. 1H NMR (300 MHz, CDCl3): d = 7.60–7.20
(m, 9 H), 7.08 (s, 1 H), 7.05–6.85 (m, 3 H), 3.79 (s, 3 H), 3.70
(s, 3 H), 3.36 (br s, 2 H). 13C NMR (75 MHz, CDCl3): d =
159.96, 159.79, 157.13, 146.90, 141.47, 139.72, 134.83,
130.52, 130.13, 129.76, 129.48, 127.96, 127.00, 126.84,
123.97, 120.48, 119.37, 117.02, 113.64, 112.53, 112.48,
55.28, 55.19, 34.36. HRMS (EI): m/z calcd for C24H22NO2
[M + H+]: 356.1645; found: 356.1644.
2,4-Bis(4-methylphenyl)-3H-1-benzazepine (2c)
Mp 147–149 °C. 1H NMR (300 MHz, CDCl3): d = 7.79 (d, 2
H, J = 6 Hz), 7.56 (dd, 1 H, J = 8, 1 Hz), 7.49–7.43 (m, 3 H),
7.37 (td, 1 H, J = 8, 2 Hz), 7.23–7.13 (m, 5 H), 7.05 (s, 1 H),
3.36 (br s, 2 H), 2.37 (s, 3 H), 2.34 (s, 3 H). 13C NMR (75
MHz, CDCl3): d = 157.04, 146.95, 140.32, 137.68, 137.12,
135.50, 134.84, 130.47, 129.68, 129.42, 129.21, 128.03,
127.94, 126.71, 126.69, 126.02, 123.69, 33.67, 21.29, 21.15.
HRMS (EI): m/z calcd for C24H22N [M + H+]: 324.1746;
found: 324.1749.
The penultimate step is proton loss to give benzazepine 6.
Presumably, this proton would be scavenged by the equiv-
alent of amine, which was produced earlier in the process.
Finally, benzazepine 6 may isomerize to benzazepine 2.
To conclude, we have found a one-pot preparation of the
benzazepine ring system using 2-fluoroaniline and aryl
methyl ketones. Efforts aimed at extending the scope to
other kinds of ketones are in progress.
Ar
Ar
CH3
N
F
N
F
2
NH2
F
Ar
H3C
–
1
3
Ar
Ar
Ar
N
F
HN
F
N
Ar
Ar
Ar
H2C
H2C
H2C
F
H
4
Ar
Ar
Ar
N
N
– F–
– H+
Ar
H
5
6
Ar
N
2,4-Bis(4-trifluoromethylphenyl)-3H-1-benzazepine (2d)
Mp 142–143 °C. 1H NMR (300 MHz, CDCl3): d = 7.95 (d, 2
H, J = 6 Hz), 7.64–7.25 (m, 10 H), 7.13 (s, 1 H), 3.39 (br s,
2 H). 19F NMR (300 MHz, CDCl3): d = –63.05 (s), –63.35
Ar
2
Scheme 2
Synlett 2007, No. 18, 2868–2870 © Thieme Stuttgart · New York